High BIRC7 Expression Might Be an Independent Prognostic Indicator of Poor Recurrence-Free Survival in Patients With Prostate Cancer.

CONCLUSION:: Based on these findings, we infer that BIRC7 upregulation might serve as a valuable biomarker of increased recurrence risk in advanced T stages and medium-grade prostate cancer. Its expression is at least regulated by both copy number alteration and DNA methylation.
PMID: 30376767 [PubMed - in process]

Source: Technology in Cancer Research and Treatment - January 1, 2018 Category: Cancer & Oncology Authors: Yang Y, Sun P, Xu W, Xia W Tags: Technol Cancer Res Treat Source Type: research